Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7/31/26 17:18 | 7/29/26 | TECH | Health | BioPrd | Biological Products, (No Diag | Hippel James | MN | O | CFO | 2 | M.d | 5,906 | 47.60 | 0 | 124 | 305 | 165 | D | ||||||||||||||
7/30/26 16:11 | 7/28/26 | TECH | Health | BioPrd | Biological Products, (No Diag | Kelderman Kim | MN | DO | CEO | 2 | M.d | 2,937 | 47.60 | 0 | 62 | 592 | 72 | D | ||||||||||||||
7/27/26 16:03 | 7/23/26 | TECH | Health | BioPrd | Biological Products, (No Diag | Bohnen Shane | MN | O | SVP - GC | 2 | M.d | 421 | 47.60 | 0 | 9 | 7 | D | |||||||||||||||
6/4/26 16:28 | 6/2/26 | TECH | Health | BioPrd | Biological Products, (No Diag | Crouse Steven C. | MN | O | P - Diag | 1 | M.d | 0 | 0.00 | 0 | 1 | 10 | 7 | D | ||||||||||||||
5/12/26 16:04 | 5/8/26 | TECH | Health | BioPrd | Biological Products, (No Diag | Herr Amy E. | MN | D | 2 | M.d | 636 | 47.94 | 0 | 13 | 3 | I | ||||||||||||||||
5/12/26 16:04 | 5/8/26 | TECH | Health | BioPrd | Biological Products, (No Diag | Herr Amy E. | MN | D | 2 | S.d | -636 | 47.94 | 0 | -13 | 3 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |